NFKB1 and myeloid sarcoma: Given the links between NF-κB/MYC signaling and PRMT5 induction in cancer (21, 22) as well as between NF-κB/MYC and MS, it is important to investigate the impact of these pathways in T cell PRMT5 expression and pathogenic T cell responses.